Dr. Colleen M. Darnell, MD

Dr. Darnell practices at St. Elizabeth Healthcare Edgewood Hospital in Edgewood, Kentucky, part of Diocese of Covington.

Dr. Darnell's NPI, 1033374046, was assigned on July 20, 2008. Dr. Darnell holds Kentucky license 49461.

Dr. Darnell's primary practice is St. Elizabeth Healthcare Edgewood Hospital, at 1 Medical Village Drive, Edgewood, KY 41017 in Kenton County. The practice phone is (859) 301-2000.

Dr. Darnell's primary practice is St. Elizabeth Healthcare Edgewood Hospital in Edgewood, Kentucky, part of Diocese of Covington. Dr. Darnell is also affiliated with St. Elizabeth Healthcare Florence Hospital. The medical group on file is St. Elizabeth Physicians. Dmand AI also links Dr. Darnell to 2 more hospitals and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Darnell practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Darnell's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Darnell's licenses on file in 2 states: Kentucky and Ohio.

CMS data shows 1,441 Medicare services from Dr. Darnell across 8 procedure codes in 2024, for 335 Medicare patients. Medicare paid $89,563 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 335 Medicare patients who saw Dr. Darnell in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Darnell's median patient age at 70, with 54% women.

In 2024, Dr. Darnell wrote 2,068 Medicare Part D claims for 321 patients. 80% of them were for generic drugs. CMS names the drug for 1,702 of them, across 50 drugs with 11 or more claims each, at $3,797,804 in total drug cost. In 2023, CMS named 1,705 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Darnell for performance year 2024, reported through an alternative payment model (APM). Dr. Darnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Darnell as offering telehealth.

Dmand AI links Dr. Darnell to 4 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Intracranial Embolism and Thrombosis. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 40 general payments to Dr. Darnell from 16 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 42% of the total. Bristol-Myers Squibb Company paid the most, $2,030. It also lists 10 research payments totaling $3,075 in 2025.